Cargando…

Moyamoya Disease May Mimic Multiple Sclerosis?

INTRODUCTION: A wide range of medical conditions may mimic multiple sclerosis. Among them, cerebrovascular diseases, including moyamoya disease, need to be excluded since they share common clinical features and radiographic findings with multiple sclerosis. CASE REPORT: A 44-year-old woman experienc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spanou, Ioanna, Evangelopoulos, Maria-Eleftheria, Velonakis, Georgios, Logiotatos, Nikolaos, Chatziioannou, Achilleas, Potagas, Constantinos, Kilidireas, Constantinos, Vassilopoulou, Sophia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521521/ https://www.ncbi.nlm.nih.gov/pubmed/31186973 http://dx.doi.org/10.1155/2019/1276950

Ejemplares similares

Moyamoya Disease: Clinical and Radiological Characteristics in Adult Greek Patients
por: Vassilopoulou, Sofia, et al.
Publicado: (2023)

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite Levels
por: Markianos, Manolis, et al.
Publicado: (2013)

Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

Early metabolic alterations in the normal‑appearing grey and white matter of patients with clinically isolated syndrome suggestive of multiple sclerosis: A proton MR spectroscopic study
por: Tzanetakos, Dimitrios, et al.
Publicado: (2023)

The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

Rituximab as Rescue Therapy for Aggressive Pediatric Multiple Sclerosis
por: Vartzelis, George, et al.
Publicado: (2019)

Increased plasma homocysteine levels in patients with multiple sclerosis and depression
por: Triantafyllou, Nikolaos, et al.
Publicado: (2008)

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course
por: Zoehner, Greta, et al.
Publicado: (2019)

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity
por: Karathanasis, Dimitris K., et al.
Publicado: (2022)

Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
por: Kazakou, Paraskevi, et al.
Publicado: (2023)

Exploring Pragmatic Deficits in Relation to Theory of Mind and Executive Functions: Evidence from Individuals with Right Hemisphere Stroke
por: Tsolakopoulos, Dimitrios, et al.
Publicado: (2023)

Immune Reconstitution Inflammatory Syndrome Mimicking Progressive Multifocal Leucoencephalopathy in a Multiple Sclerosis Patient Treated With Natalizumab: A Case Report and Review of the Literature
por: Evangelopoulos, Maria-Eleptheria, et al.
Publicado: (2015)

Serum Leptin Levels in Treatment-Naive Patients with Clinically Isolated Syndrome or Relapsing-Remitting Multiple Sclerosis
por: Evangelopoulos, Maria Eleftheria, et al.
Publicado: (2014)

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases
por: Vakrakou, Aigli G., et al.
Publicado: (2021)

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature
por: Vakrakou, Aigli G., et al.
Publicado: (2020)

Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis
por: Tzanetakos, Dimitrios, et al.
Publicado: (2022)

Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
por: Koros, Christos, et al.
Publicado: (2013)

Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece
por: Dardiotis, Efthymios, et al.
Publicado: (2022)

The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials
por: Tsivgoulis, Georgios, et al.
Publicado: (2016)

Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts
por: Tzanetakos, D., et al.
Publicado: (2020)

Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study
por: Miclea, Andrei, et al.
Publicado: (2018)

The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease
por: Filippiadis, Dimitrios K., et al.
Publicado: (2021)

Severe Murine Typhus Presenting with Acalculous Cholecystitis: A Case Report and Literature Review
por: Spernovasilis, Nikolaos, et al.
Publicado: (2017)

Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response
por: Evangelopoulos, Maria Eleftheria, et al.
Publicado: (2021)

A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How
por: Si, Xiaoli, et al.
Publicado: (2020)

Author Correction: Methylprednisolone stimulated gene expression (GILZ, MCL-1) and basal cortisol levels in multiple sclerosis patients in relapse are associated with clinical response
por: Evangelopoulos, Maria Eleftheria, et al.
Publicado: (2021)

Smell as a Disease Marker in Multiple Sclerosis
por: Printza, Athanasia, et al.
Publicado: (2022)

Homonymous hemianopsia as the leading symptom of a tumor like demyelinating lesion: a case report
por: Evangelopoulos, Maria Eleptheria, et al.
Publicado: (2009)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Aggressive Herpes Zoster in Young Patients With Multiple Sclerosis Under Dimethyl Fumarate: Significance of CD8(+) and Natural Killer Cells
por: Anagnostouli, Maria C., et al.
Publicado: (2021)

The Role of the Right Hemisphere White Matter Tracts in Chronic Aphasic Patients After Damage of the Language Tracts in the Left Hemisphere
por: Kourtidou, Evie, et al.
Publicado: (2021)

Specific disruption of the ventral anterior temporo-frontal network reveals key implications for language comprehension and cognition
por: Kourtidou, Evie, et al.
Publicado: (2022)

Capecitabine Induced Multifocal Leukoencephalopathy: Do We Have Always to Switch off the Chemotherapy?
por: Bougea, Anastasia, et al.
Publicado: (2016)

Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study
por: Diem, Lara, et al.
Publicado: (2020)

A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes
por: Vakrakou, A. G., et al.
Publicado: (2018)

Solitary round pulmonary lesions in the pediatric population: a pictorial review
por: Arkoudis, Nikolaos-Achilleas, et al.
Publicado: (2019)

Motor and Non-motor Features: Differences between Patients with Isolated Essential Tremor and Patients with Both Essential Tremor and Parkinson’s Disease
por: Ghika, Apostolia, et al.
Publicado: (2015)

The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis
por: Christidi, Foteini, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2r9r5teefcq0m69k4polvlum8h